Integrating Financial Coaching and Smoking Cessation Coaching - Trial NCT05154669
Access comprehensive clinical trial information for NCT05154669 through Pure Global AI's free database. This Phase 3 trial is sponsored by NYU Langone Health and is currently Recruiting. The study focuses on Smoking. Target enrollment is 900 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
NYU Langone Health
Timeline & Enrollment
Phase 3
Dec 06, 2022
Jan 01, 2027
Primary Outcome
Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (salivary cotinine),Effectiveness of the integrated intervention to standard cessation counseling on long-term abstinence (CO concentration)
Summary
This study conduct a two-arm, parallel-group randomized controlled trial. The study will
 recruit and randomize 900 smokers (n=450 per arm) to either: (1) Control: Standard Smoking
 Cessation Counseling or (2) Intervention: Integrated Financial-Smoking Cessation Counseling.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05154669
Non-Device Trial